Animal healthcare firm Hester Biosciences Tuesday reported 82 per cent rise in standalone net profit at Rs 11.85 crore for the third quarter ended December, 2018.
The company had posted a net profit of Rs 6.50 crore in the same period of the previous fiscal, Hester Biosciences said in a BSE filing.
Its standalone net sales stood at Rs 41.55 crore for the quarter under consideration as against Rs 31.92 crore in the year-ago period.
Shares of Hester Biosciences were trading at Rs 1,130 per scrip on the BSE, up 3.67 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app